Clarity is needed from the Boards of Appeal on the EPO's "co-applicant approach" to priority
The high-profile CRISPR patent dispute relates to the EPO interpretation of "any applicant" in Article 87(1) EPC (IPKat post he...
Dr Rose Hughes -
Thursday, November 28, 2019
Clarity is needed from the Boards of Appeal on the EPO's "co-applicant approach" to priority
Reviewed by Dr Rose Hughes
on
Thursday, November 28, 2019
Rating:
Reviewed by Dr Rose Hughes
on
Thursday, November 28, 2019
Rating: